These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6135771)

  • 1. The influence of pH of dissolution fluid and particle size of drug on the in-vitro release of drug from hard gelatin capsules.
    Muhammad NA; Newton JM
    J Pharm Pharmacol; 1983 Jun; 35(6):345-9. PubMed ID: 6135771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of agitation intensity, particle size and pH of dissolution fluid on the in-vitro release of drug from hard gelatin capsules.
    Newton JM; Muhammad NA
    J Pharm Pharmacol; 1984 Jan; 36(1):42-4. PubMed ID: 6141262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of drug and diluent particle size on the in vitro release of drug from hard gelatin capsules.
    Newton JM; Bader F
    J Pharm Pharmacol; 1980 Mar; 32(3):167-71. PubMed ID: 6103930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angle of internal flow as an indicator of filling and drug release properties of capsule formulations.
    Newton JM; Bader F
    J Pharm Pharmacol; 1987 Mar; 39(3):164-8. PubMed ID: 2883278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):327-34. PubMed ID: 8064556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the release of aspirin from spray-congealed micro-pellets.
    Guo QY; Chan LW; Heng PW
    J Microencapsul; 2005 May; 22(3):245-51. PubMed ID: 16019910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prediction of the bulk densities of powder mixtures, and its relationship to the filling of hard gelatin capsules.
    Newton JM; Bader F
    J Pharm Pharmacol; 1981 Oct; 33(10):621-6. PubMed ID: 6117613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations into the relationship between drug properties, filling, and the release of drugs from hard gelatin capsules using multivariate statistical analysis.
    Hogan J; Shue PI; Podczeck F; Newton JM
    Pharm Res; 1996 Jun; 13(6):944-9. PubMed ID: 8792437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a slow-release capsule using laser drilling.
    Jain NK; Naik SU
    J Pharm Sci; 1984 Dec; 73(12):1806-11. PubMed ID: 6527262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofibrate microcapsules: preparation and release rat studies.
    Madan PL; Madan DK; Price JC
    J Pharm Sci; 1976 Oct; 65(10):1476-9. PubMed ID: 978405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol.
    Soliman MS; Khan MA
    Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation development and in vitro evaluation of theophylline microcapsules.
    Ahmad M; Akhtar N; Murtaza G; Hussain SW
    Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The release of a model low-dose drug (riboflavine) from hard gelatin capsule formulations.
    Stewart AG; Grant DJ; Newton JM
    J Pharm Pharmacol; 1979 Jan; 31(1):1-6. PubMed ID: 32357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique.
    Ugwoke MI; Kinget R
    J Microencapsul; 1998; 15(3):273-81. PubMed ID: 9608392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: The interaction of formulation factors and dissolution fluid and the in vitro release of drug from hard gelatin capsules.
    Newton JM; Razzo RN
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():78P. PubMed ID: 2755
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
    Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
    Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.